Interferon-based HBV function cure therapy reduces hepatocellular carcinoma risk in low-HBsAg chronic hepatitis B patients: a propensity-matched cohort study and dynamic prediction model.
- DOI
- 10.3389/fimmu.2026.1955742
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1955742,
title = {Interferon-based HBV function cure therapy reduces hepatocellular carcinoma risk in low-HBsAg chronic hepatitis B patients: a propensity-matched cohort study and dynamic prediction model.},
author = {Gu Y and Wang P and Xu Q and Liu T and Xie H and Wu B and Jie Y and Li X},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1955742},
url = {https://doi.org/10.3389/fimmu.2026.1955742}
}RIS
TY - JOUR TI - Interferon-based HBV function cure therapy reduces hepatocellular carcinoma risk in low-HBsAg chronic hepatitis B patients: a propensity-matched cohort study and dynamic prediction model. AU - Gu Y AU - Wang P AU - Xu Q AU - Liu T AU - Xie H AU - Wu B AU - Jie Y AU - Li X PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1955742 UR - https://doi.org/10.3389/fimmu.2026.1955742 ER -
APA
Y, G., P, W., Q, X., T, L., H, X., B, W., Y, J., & X, L. (2026). Interferon-based HBV function cure therapy reduces hepatocellular carcinoma risk in low-HBsAg chronic hepatitis B patients: a propensity-matched cohort study and dynamic prediction model.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1955742
Source records
- pubmed · retrieved 2026-11-10T20:17:50.325Z
- europe-pmc · retrieved 2026-11-10T20:17:50.335Z
- doaj · retrieved 2026-11-10T20:17:50.323Z